China Medicine Corporation (CHME)
OTCMKTS · Delayed Price · Currency is USD
0.0350
+0.0025 (7.69%)
At close: Jan 6, 2026
China Medicine Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
|---|---|---|---|---|---|---|
Period Ending | Sep '10 Sep 30, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 |
Net Income | 6.03 | 1.72 | 9.13 | 6.88 | 4.79 | 5.69 |
Depreciation & Amortization | 1.7 | 1.01 | 0.42 | 0.3 | 0.16 | 0.1 |
Other Amortization | - | - | - | 0.33 | - | - |
Loss (Gain) From Sale of Assets | -0.01 | 0.02 | 0.01 | - | 0.02 | -0.34 |
Loss (Gain) From Sale of Investments | - | - | - | - | 0.11 | - |
Stock-Based Compensation | 0.26 | 0.13 | 0.09 | 0.33 | 0.69 | - |
Provision & Write-off of Bad Debts | 0.16 | 0.05 | 0.04 | 0.02 | - | - |
Other Operating Activities | 2.07 | 7.23 | - | - | - | -0.07 |
Change in Accounts Receivable | -1.15 | -2.28 | -4.79 | -5.88 | -4.51 | -1 |
Change in Inventory | 3.54 | 3.37 | -0.49 | -1.84 | -0.5 | -1.54 |
Change in Accounts Payable | -0.11 | 0.61 | -0.02 | -0.12 | 0.02 | -0.32 |
Change in Unearned Revenue | 0.59 | 0.33 | -0.06 | 0.18 | -0.02 | -0.66 |
Change in Income Taxes | 0.65 | 0.45 | 0.27 | 0.15 | 0.12 | -0.11 |
Change in Other Net Operating Assets | -2.43 | 4.64 | -0.26 | -2.56 | -3.06 | -0.58 |
Operating Cash Flow | 11.01 | 16.96 | 4.21 | -2.31 | -2.22 | 1.17 |
Operating Cash Flow Growth | 29.76% | 302.92% | - | - | - | -53.93% |
Capital Expenditures | -4.58 | -3.44 | -2.67 | -0.39 | -0.83 | -0.17 |
Sale of Property, Plant & Equipment | -0 | 0.02 | - | - | - | - |
Cash Acquisitions | -8 | -8 | - | - | - | - |
Sale (Purchase) of Intangibles | 0 | -0.23 | - | - | -0 | 0.61 |
Other Investing Activities | 2.27 | -1.88 | -5.2 | - | - | - |
Investing Cash Flow | -10.3 | -13.54 | -7.86 | -0.39 | -0.83 | 0.45 |
Short-Term Debt Issued | - | 6.6 | - | - | - | 0.1 |
Total Debt Issued | 8.72 | 6.6 | - | - | - | 0.1 |
Short-Term Debt Repaid | - | -10.64 | - | - | -0.09 | - |
Total Debt Repaid | -22.08 | -10.64 | - | - | -0.09 | - |
Net Debt Issued (Repaid) | -13.36 | -4.04 | - | - | -0.09 | 0.1 |
Issuance of Common Stock | 13.07 | 0.05 | 0.36 | 7.83 | - | - |
Repurchase of Common Stock | -0.88 | - | - | - | -0.17 | - |
Other Financing Activities | -51.67 | -1.76 | - | - | -0.03 | - |
Financing Cash Flow | 4.76 | -5.75 | 0.36 | 7.83 | 3.49 | -1.8 |
Foreign Exchange Rate Adjustments | 0.15 | 0.01 | 0.32 | 0.27 | -0.16 | 0.03 |
Net Cash Flow | 5.61 | -2.32 | -2.98 | 5.4 | 0.28 | -0.15 |
Free Cash Flow | 6.43 | 13.52 | 1.54 | -2.7 | -3.04 | 1.01 |
Free Cash Flow Growth | 157.81% | 776.21% | - | - | - | -60.35% |
Free Cash Flow Margin | 9.78% | 20.88% | 2.88% | -6.41% | -12.69% | 6.74% |
Free Cash Flow Per Share | 0.20 | 0.88 | 0.10 | -0.20 | -0.40 | 0.15 |
Cash Interest Paid | 0.3 | 0.08 | - | - | - | 0 |
Cash Income Tax Paid | 2.65 | 3.22 | 2.06 | 1.57 | 1.24 | 0 |
Levered Free Cash Flow | -44.62 | 10.04 | -2.34 | -5.44 | -2.59 | 0.72 |
Unlevered Free Cash Flow | -44.48 | 10.04 | -2.34 | -5.44 | -2.59 | 0.72 |
Change in Working Capital | 1.09 | 7.11 | -5.35 | -10.07 | -7.96 | -4.21 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.